ストックスクリーナーアプリを入手
230.11
0.96%
-2.24
アフターアワーズ：
229.89
-0.22
-0.10%
Abbvie Inc (ABBV) 最新ニュース
Is AbbVie (ABBV) Still Priced Attractively After Its Strong Multi Year Share Price Run - Yahoo Finance Singapore
AbbVie (NYSE:ABBV) SVP David Ryan Purdue Sells 5,230 Shares - MarketBeat
AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
AbbVie (ABBV) Up 6.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance Singapore
These 3 Cash Flow Machines Provide Stability in Uncertain Markets - Investing.com
Will AbbVie's Neuroscience Segment Continue to Aid Top Line in 2026? - TradingView
Edgar Lomax Co. VA Reduces Stock Position in AbbVie Inc. $ABBV - MarketBeat
Crossmark Global Holdings Inc. Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Berry Wealth Group LP Lowers Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie to invest $380 million in North Chicago campus to make next generation medicines - Daily Herald
AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Chronic Idiopathic Constipation Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland - Barchart.com
Evercore ISI Adjusts AbbVie Price Target to $233 From $228, Maintains Outperform Rating - marketscreener.com
AbbVie (ABBV) Completes $7.75 Billion Notes Offering - GuruFocus
GW&K Investment Management LLC Sells 6,207 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Completes $8 Billion Senior Notes Financing Offering - TipRanks
Immunology, Obesity And Other Insights From The TD Cowen Healthcare Conference - Citeline News & Insights
US287YEG0 Bond Price and Chart — MUN:US287YEG0 - TradingView
AbbVie: Stabilizes Near $233 While Testing Resistance - Seeking Alpha
AbbVie: The Only Big Pharma Stock I'd Consider a Buy‑and‑Never‑Sell - The Globe and Mail
Uterine Fibroid Treatment Drugs Market Is Going to Boom Rapidly | - openPR.com
AbbVie stock price forecast: Stabilizes near $233 while testing resistance - Traders Union
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS - AbbVie News Center
Neurogenic Detrusor Overactivity Market Is Going to Boom Rapidly | Astellas Pharma Inc., Allergan plc (AbbVie Inc.) - openPR.com
Griffith & Werner Inc. Invests $2.64 Million in AbbVie Inc. $ABBV - MarketBeat
Picton Mahoney Asset Management Has $25.14 Million Stake in AbbVie Inc. $ABBV - MarketBeat
How Positive Crohn’s Phase 3 Data for SKYRIZI Could Impact AbbVie (ABBV) Investors - simplywall.st
Dimensional Fund Advisors LP Has $2.06 Billion Position in AbbVie Inc. $ABBV - MarketBeat
Cresset Asset Management LLC Sells 15,199 Shares of AbbVie Inc. $ABBV - MarketBeat
Perry Siatis Sells 18,668 Shares of AbbVie Inc (ABBV) - GuruFocus
AbbVie (ABBV) EVP Roopal Thakkar reports tax-withholding share disposition - Stock Titan
AbbVie CEO reports tax-withholding share disposition | ABBV SEC FilingForm 4 - Stock Titan
AbbVie (NYSE: ABBV) EVP reports tax-withholding share disposition - Stock Titan
AbbVie (NYSE: ABBV) EVP Perry Siatis sells 18,668 shares - Stock Titan
AbbVie (ABBV) CFO uses 21,638 shares to cover tax withholding - Stock Titan
AbbVie (ABBV) SVP Purdue disposes 2,692 shares for tax withholding - Stock Titan
AbbVie (NYSE: ABBV) EVP uses shares to cover tax withholding - Stock Titan
PRESCRIPTION DRUGS—M.D. Tenn.: Court rejects AbbVie’s challenge to Tennessee contract pharmacy law - VitalLaw.com
US287YEJ4 Bond Price and Chart — FWB:US287YEJ4 - TradingView
AbbVie at TD Cowen: Strategic Insights and Growth Outlook - Investing.com
AbbVie to Present at the Leerink Partners Global Healthcare Conference - Investing News Network
Harvest Portfolios Group Reduces Stake in AbbVie - National Today
Victory Capital Management Inc. Buys 120,490 Shares of AbbVie Inc. $ABBV - MarketBeat
State Farm Mutual Automobile Insurance Co. Sells 69,551 Shares of AbbVie Inc. $ABBV - MarketBeat
Hear AbbVie management live at Leerink global healthcare conference - Stock Titan
Level Four Advisory Services LLC Trims Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Hits $31 Billion in Skyrizi and Rinvoq Sales - TIKR.com
Fisher Asset Management LLC Decreases Holdings in AbbVie Inc. $ABBV - MarketBeat
CI Investments Inc. Has $41.19 Million Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie to invest $380M in new North Chicago API manufacturing facilities - Chicago Construction News
AbbVie’s New Data And Approval Test Growth And Valuation Story - Yahoo Finance
ABBV (NYSE: ABBV) Form 144: Director sale of 22,381 shares noted - Stock Titan
FDA Grants Orphan Drug Status to AbbVie's (ABBV) Neuroendocrine Carcinoma Treatment - GuruFocus
Why AbbVie Stock May Be the Ultimate Option for Dividend Investors - Nasdaq
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® Subcutaneous Induction in Patients with Crohn's Disease - Investing News Network
AbbVie (ABBV) Reports Positive Phase 3 Results in Crohn's Diseas - GuruFocus
AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant With A 7.16% Potential Upside - DirectorsTalk Interviews
AbbVie’s Skyrizi shows positive results in Crohn’s disease trial - Investing.com
Crohn's patients see higher remission with AbbVie's SKYRIZI shot - Stock Titan
AbbVie Inc. $ABBV Shares Purchased by Elo Mutual Pension Insurance Co - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Trimmed by Laurel Wealth Advisors LLC - MarketBeat
Bahl & Gaynor Inc. Has $730.34 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by 111 Capital - MarketBeat
Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now? - Insider Monkey
AbbVie's major product revenues from 2023 to 2025 - Statista
AbbVie Inc. $ABBV Shares Sold by R Squared Ltd - MarketBeat
AbbVie Inc. $ABBV Shares Sold by APG Asset Management N.V. - MarketBeat
AbbVie stock price jumps 3% into weekend as $8 billion bond sale nears settlement - TechStock²
Westfield Capital Management Co. LP Takes $1.84 Million Position in AbbVie Inc. $ABBV - MarketBeat
Harvest Portfolios Group Inc. Has $66.12 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Huntington National Bank Purchases 24,310 Shares of AbbVie Inc. $ABBV - MarketBeat
American Century Companies Inc. Cuts Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) EVP Perry Siatis Sells 22,381 Shares - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 3.1%Time to Buy? - MarketBeat
0.55%
0.32%
大文字化:
|
ボリューム (24 時間):